SARS (Severe Acute Respiratory Syndrome) Completed Phase 2 / 3 Trials for Hydroxychloroquine (DB01611)

Also known as: Severe Acute Respiratory Syndrome (SARS) / Severe Acute Respiratory Syndrome / Respiratory Syndrome, Acute, Severe / SARS (Disease) / SARS-CoV-1 infection / SARS / Severe acute respiratory syndrome (disorder) / Severe acute respiratory syndrome NOS

IndicationStatusPhase
DBCOND0127071 (SARS (Severe Acute Respiratory Syndrome))Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04328961Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP)Prevention